Senior insider sale
Chief Legal Officer at KYMERA THERAPEUTICS, INC. — senior position signals high conviction
$747.2K
6.37K shares
What this filing means
ADAMS BRIAN plans to sell 6.37K shares of KYMERA THERAPEUTICS, INC. valued at approximately $747.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/4/2026ACC: 0001193125-26-383667
Officer· Chief Legal Officer
Since Mar 2026
6.37K
Shares to sell
$747.2K
Approx. market value
6.37K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Shares acquired upon vesting of Restricted Stock Units awarded under the Issuer's 2020 Equity Incentive Plan.
Equity compensation
9/3/2026
6.37KTotal acquired6.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/3/2026 | Shares acquired upon vesting of Restricted Stock Units awarded under the Issuer's 2020 Equity Incentive Plan. Equity compensation | 6.37K | — |
| Total | 6.37K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.37K
Market value
$747.2K
9/4/2026
Total
Units
6.37K
Value
$747.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/4/2026 | 6.37K | $747.2K | NASDAQ | Planned |
| Total | 6.37K | $747.2K | ||